Increasing evidence supports the hypothesis that amyloid -protein (A) assembly is a key pathogenic feature of Alzheimer's disease. Thus, understanding the assembly process offers opportunities for the development of strategies for treating this devastating disease. In prior studies, A was found to form micelle-like aggregates under acidic conditions. These structures exhibited an average observed hydrodynamic radius of 7 nm. They were found to be in rapid equilibrium with A monomers or low molecular weight oligomers, and were centers of fibril nucleation. Here the technique of small angle neutron scattering has been used to determine the structure of these A micelles. The data reveal that the micellar assemblies comprise 30 -50 A monomers and have elongated geometries. The best fit of the data to a uniform spherocylinder yields a radius Ϸ2.4 nm and cylinder length Ϸ11 nm. These structure parameters remain constant over more than a decade in concentration range. The concentration independence of the length of the cylindrical aggregate indicates the presence of an internal nonrepetitive structure that spans the entire length of the A assembly. A lzheimer's disease (AD) is a progressive neurodegenerative disorder characterized in part by extensive amyloid deposition in the brain parenchyma and vasculature (1). These amyloid deposits are formed by the amyloid -protein (A), a proteolytic fragment of the larger amyloid -protein precursor (APP) (2). Compelling data support the hypothesis that A production and fibril assembly are linked to AD (3). For example, mutations in gene encoding APP, or in genes encoding proteins involved in the A metabolism, are associated with familial forms of AD or of cerebral amyloid angiopathy. In all cases thus far studied, these mutations increase A production, increase the relative amount of the particularly amyloidogenic 42-residue form of A, or alter the biophysical properties of the mutant A peptide facilitating its self-association or retarding its catabolism. Recent studies in humans, in transgenic mice, and in vitro, suggest that important effectors of A-mediated neuronal injury and death may be small oligomeric assemblies of A (4). Understanding the earliest phases of A fibril formation, in particular oligomerization and other prenucleation interactions, is thus of great importance for identifying potential therapeutic targets.Previously (5), quasielastic light scattering (QLS) spectroscopy was used to monitor the kinetic evolution of the size distribution of A(1-40) assemblies formed under acidic conditions. These experiments showed that above a critical concentration c* Ϸ 0.1 mM, A formed micelle-like structures with an average observed hydrodynamic radius R h Ϸ 7 nm. These micelles ʈ formed immediately on dissolution of the protein and were in equilibrium with low molecular weight, possibly monomeric, components of the A solution. Analysis of the temporal evolution of the fibril length distribution at different total A concentrations revealed that micel...